Genetic Engineering & Biotechnology News

SEP15 2016

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D; community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/723909

Contents of this Issue

Navigation

Page 89 of 89

P a l l L i f e S c i e n c e s ' N e w E n g l a n d C e n t e r o f E x c e l l e n c e • W e s t b o r o u g h , M a s s a c h u s e t t s – U S A • Pall Life Sciences has built the most comprehensive bioprocessing technology and service portfolio on the market. Pall Life Sciences has spent the last decade building out an unmatched portfolio of traditional and single-use technologies. Our team is leading the way towards continuous processing, and invite you to learn more about the next generation Cadence™ platform. This unparalled suite of products features innovative unit operations which leverage single-use technologies to enable full or partial continuous processing for mAbs, recombinant proteins and other biotheraputics. Visit www.pall.com/continuous to learn more enabling technologies, and exceptional scientific support to continuously improve the economics, quality and flexibility of your bioprocesses. Continuously Improving Bioprocesses © 2016 Pall Corporation. Pall, and Cadence are trademarks of Pall Corporation. ® indicates a trademark registered in the USA. GN16.9940 Who wants a continuous future? Want to learn more? Visit us at BioProcess International 2016 booth #521

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - SEP15 2016